National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the aisle on Tuesday that his biomedical research agency is on the right track.
The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.
People living with HIV represent a unique population in the field of infectious disease and immunology due to persistent immune dysregulation and an ...
For four decades, researchers around the world have been trying to develop a vaccine for HIV without any luck. Recently, though, there has been some good news. Linda-Gail Bekker directs the Desmond ...
A safe, effective, and durable preventive HIV vaccine is widely recognized as essential to reducing new infections and achieving lasting epidemic control at a population level. Despite decades of ...
One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and antibodies. In most vaccines, HIV proteins are attached to a larger protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results